Where are the headlines?
Merck in court over Gardasil! This is exciting news. It is vitally important news especially for teenagers who are injected with dangerous and useless HPV vaccines. Continue reading
Merck in court over Gardasil! This is exciting news. It is vitally important news especially for teenagers who are injected with dangerous and useless HPV vaccines. Continue reading
There are three forms of aluminium which are used as adjuvants in vaccines in order to bring about an immune response:
Each shot of Merck’s HPV vaccine, Gardasil, contains 225 micrograms of amorphous aluminium hydroxyphosphate sulphate and Gardasil 9 contains 500 mcgs of the same adjuvant.
Of all the vaccines in 2017, parents report Gardasil to be the most reactive vaccine in adolescents. The stories we hear and the cases I’ve seen are horrendous.
—Dr. Suzanne Humphries
The three types of aluminium work differently in the body. They are not the same – they are not just interchangeable. These 3 types of aluminium adjuvants differ in how they affect the immune system and so it is vital that we know which adjuvant has been used in a particular vaccine. And yet, it is assumed that what is listed on the package insert on any vaccine is what is in the vial.
We expect that each vaccine is labelled clearly and states what type of aluminium has been used as the adjuvant. But sadly this is not the case. Standardization of aluminium is a problem because particle sizes vary and this presents consistency problems.
In Merck’s Dirty Little Secret, Dr. Suzanne Humphries wonders why Gardasil hits the immune systems of some of these teenagers so ‘viciously,
“By Merck’s own admission for every 100,000 people who use Gardasil or Gardasil 9 you expect a minimum of 2300 serious adverse events to combat 12 potential cases of cervical cancer.”
A vial of Gardasil contains AAHS or amorphous aluminium hydroxyphospate sulphate chosen because it ‘binds better to the protein antigen and promotes a bigger immune system bonfire with more antibodies.’
Dr. Humphries states that although she always knew that no child can be standardized, she used to believe that vaccines could be, and claims that we cannot be sure that what is printed on the vaccine label matches what is actually in the vaccine.
Dr. Humphries explains the research done by Shirodkar in 1990 in which the whole-cell DPT vaccine label manufactured by Connaught Laboratories listed the adjuvant as ‘aluminium potassium sulphate’ but was really ‘amorphous aluminium hydroxyphosphate sulphate’ or AAHS, the same adjuvant used in Gardasil.
The diptheria and tetanus toxoids that make up the highly problematic whole cell diptheria, pertussis and tetanus vaccines contain the same adjuvant AAHS as is used today in Gardasil.
Could it be that the aluminium might have played a role in the reactions said to be because of the pertussis endotoxin in the whole cell DPT vaccines? Interestingly, there were many reactions in children who were given just the diptheria and tetanus toxoid vaccines. These vaccines did not contain the pertussis endotoxin.
A New Zealand hepatitis B package insert from 1987 states that the adjuvant used was aluminium hydroxide. However the labelling was wrong and had to be changed to amorphous aluminium hydroxyphosphate meaning that the hepatitis B vaccines were mislabeled for more than a decade and in reality, contained a more reactive adjuvant and one that was difficult to standardize.
Another example was the mislabelling of New Zealand’s VAQTA or the Hepatitis A vaccine. The 1994 package stated that it contained aluminium hydroxide. However this was incorrect with Merck requesting the label be changed to reflect that the vaccine contained amorphous aluminium hydroxyphospate sulphate or AAHS. And remember these adjuvants react differently in the body so it is vital that labels are correct.
We now know that Merck’s vaccines have always contained AAHS in them.
For decades these labels have been incorrect.
Dr. Humphries explains an important implication and one that nullifies the Cochrane Review into aluminium.
In 2004 a Cochrane review of aluminium was undertaken and published in The Lancet,
“We found no evidence that aluminium salts in vaccines cause any serious or long-lasting adverse events. Despite a lack of good-quality evidence we do not recommend that any further research on this topic is undertaken.”
But as Dr. Humphries points out, these reviews were performed on aluminium hydroxide or aluminium phosphate where in reality the vaccines contained amorphous aluminium hydroxyphosphate sulphate or AAHS.
“The fact is that by 2004 vaccine manufacturers knew full well that the labelling was false and never informed.”
– Dr. Thomas Jefferson
The repercussions of this as activist, Elizabeth Hart, suggests:
“Jefferson et al’s scientifically unsound review has facilitated poorly evidenced acceptance of the safety of aluminium-adjuvanted vaccines. As a consequence, an increasing number of aluminium-adjuvanted vaccines are being added to vaccination schedules around the world… The long-term cumulative effects of the ever-growing list of vaccine products are unknown.”
The number of girls and boys experiencing adverse events following their Gardasil vaccination continues to grow at a faster and more alarmingly rate than that of other vaccines. To date, there are over 85,000 reports on the World Health Organisation’s database, VigiBase. The use of amorphous aluminium hydroxyphosphate sulphate or (AAHS) causes the immune system to become 104 times more powerfully stimulated than what would occur naturally. Such overstimulation of the immune system results in the development of more dangerous allergies, especially asthma. It also causes the manifestation of autoimmune diseases and seizures and all of the conditions that are occurring in our young teenagers after HPV vaccination including POTS or postural orthostatic tachycardic syndrome, gastrointestinal problems, heart disease, cancer, hair loss, depression, insomnia, and excruciating joint pain.
Aluminium is indeed, immunology’s dirty little secret.
I am horrified to read that the latest group being targeted as possible recipients of Gardasil are pregnant women.
Markab Algedi writes that the University of Alabama at Birmingham along with vaccine producer Merck plan to trial Gardasil 9 on postpartum mothers. The women who agree to be part of the trial will be between the ages of 16 and 26, and receive the vaccine immediately after having their children at the UAB hospital.
Here is the part of the summary of the trial as described on the ClinicalTrials.gov website. The trial will start in June 2018 with an estimated enrollment of 200 mothers.
Due to low HPV vaccine uptake in the US, innovative approaches to vaccinating vulnerable populations are necessary in order to maximize the cancer prevention potential of this vaccine. The puerperium is a time period when women are engaged in the healthcare system and have almost universal access to affordable health care. Two prior studies have shown that postpartum HPV vaccination is acceptable to patients, and high rates of vaccination were achieved in these primarily Hispanic populations. However, data show that the immune response in young women is less robust than in adolescents, and no studies have examined immunogenicity in postpartum women specifically. We propose an HPV vaccination pilot study in women who receive postpartum care at University of Alabama at Birmingham (UAB) hospital. We will examine the acceptability, uptake and immunogenicity of the vaccine in the postpartum setting.
The most frequently reported reactions manifest as autoimmune disorders such as arthritis, vasculitis, systemic lupus erythematosus (SLE) and neurological diseases such as encephalopathy, neuropathy, and seizure disorders. But other bodily systems are affected with increasing reports of premature ovarian failure and infertility in young girls. Then there’s the very serious gastrointestinal disorders, cancer and death. This is a vaccine which should be taken off the market, not extended to new mothers.
Gardasil is described as one the worst vaccines ever produced and responsible for more adverse events than any other. There are 30,000 videos on You Tube documenting the disaster and the ruined lives of young girls and now boys. Do those proposing to vaccinate young mothers have any idea how this vaccine might affect the infant? As well as containing the HPV antigens 6, 11, 16, 18, 31, 33, 45, 52, and 58, Gardasil 9 also contains 500 mcgs of aluminium adjuvant, yeast protein, L-histidine, polysorbate 80 and sodium borate. Polysorbate 80 and sodium borate have been linked to infertility in rats and therefore should not form part of any vaccine given to young women. Aluminium is a proven neurotoxin and once injected in the body can migrate and accumulate in the brain. Scientists at Keele University have recently discovered the way the aluminium in vaccine adjuvants travels from the site of injection to the brain. Another Gardasil additive L-histidine causes vasodilation and may be the reason for the common dangerous symptom of syncope or collapse experienced by many girls following Gardasil.
Gardasil and lactation
A search of Clinical Studies in Humans reveals that it is not known whether vaccine antigens or antibodies induced by the vaccine are excreted in human milk. This is clearly not very reassuring and this information should form part of any informed consent that young women are given.
Premature menopause and infertility
And what about the known effects of Gardasil on the reproductive system of girls and women which include premature menopause. Dr Deidre Little is an Australian doctor who questions the safety of the Gardasil vaccine. In the BMJ Case Reports authors Deidre Little and Harvey Rodrick Grenville Ward reported the case of a patient with amenorrhoea who had noticed that her usual regular menstrual cycle had changed, becoming irregular and then scant after her HPV vaccinations. The authors explain that it is very rare for the condition known as premature ovarian failure to occur at such an early age and that the annual incidence is 10 per 100,000 between 15 and 29 years of age. Premature ovarian failure is a serious health event for young girls and one that adversely affects their ability to have children.
Are these postpartum women informed of possible risks to their future ability to have children? This vaccine needs to be recalled, not trialled and marketed to more vulnerable people.
- In a trial sponsored by the National Institute of Child Health in Hungary, in collaboration with Merck, researchers are testing the 4-valent Gardasil vaccine in children to treat recurrent respiratory paillomatosis (RRP), a rare childhood disease caused by HPV
- Initially the study was to enroll children as young as 1 year old with RRP and administer three doses of HPV vaccine to “assess response to vaccination,” but recent study details indicate the tests are ongoing in children as young as 28 days old
- The study’s status remains unknown, as it has not yet been reported as completed
It is not surprising and indeed it is heartening to hear that a young woman from Ireland is suing Merck, the manufacturer of Gardasil, the Irish Health Service Executive (HSE), the health minister, the education minister, the attorney-general and the state.
The woman who became ill after her Gardasil vaccination joins many other groups of women who are now suing the manufacturer of Gardasil and the state. There are six other cases over Gardasil before the Irish courts. A class action against the manufacturers of Gardasil began on August 4, 2017 on behalf of 700 Columbian women who in March 2014 were admitted to the hospital suffering new medical conditions following their HPV vaccination. And in Japan twenty-eight girls and women suffering side effects from cervical cancer vaccines that were recommended by the government are demanding compensation from the state.
In Australia to date there are over 4000 adverse events and one death from Gardasil reported to the Therapeutic Goods Administration. We really need to ask what the TGA is doing about this situation? What will it take for our health watchdog to take action?
As the Australian school year begins it’s time to think about vaccines, especially if you are a parent of a young teenager. From this year, Gardasil 9, the latest human papilloma virus vaccine will be given to all Australian 12 and 13-year-old students. But what do you know about this vaccine? Before you sign the consent form which in no way informs you or your child, please do some research and then decide what is right for your situation.
Gardasil 9 was approved for use in Australia by the TGA last year and is said to be protective against nine HPV types: 6, 11, 16, 18, 31, 33, 45, 52, and 58. This new vaccine supersedes the quadrivalent HPV vaccine – Gardasil, which has been given to girls and women since 2007 and to teenage boys from 2013. For more on the possible adverse effects of this vaccine please read my article What parents should know about Gardasil 9
And as you research this vaccine be ever mindful that there is no need for Gardasil 9. According to the VAERS reporting system this new HPV vaccine is already responsible for over 7000 adverse events. There is no need for Gardasil either, a very sore point for the women, girls and boys who have become so very ill after HPV vaccination that they cannot go to school or even look after themselves.
The reason this vaccine was hyped, developed and marketed was it was supposed to be a vaccine that would prevent cervical cancer. But there is no epidemic of this disease in western nations such as Australia. Cervical cancer is detected by Pap smears and to date this vaccine has not prevented a single case of the disease. As of this month there have been over 83,000 adverse effects after Gardasil vaccination recorded on the World Health Organisation’s website. These severe adverse effects are increasing; there is no letting up on the damage being done in the wake of this unnecessary vaccine. In June 2017 the amount of severe adverse events recorded on this WHO website was 73000. One has to seriously wonder why these vaccines are not stopped. What is the use of collating this long list of adverse events if there is to be no action.
When will we see a class action take place in Australia? Many girls still do not know where or how to report their vaccine damage. Here is the link where you can report your reaction. Of course many girls and their families do not even connect the vaccination with their newly developed disease so there is certain to be more damage which is not being recorded to the TGA.
What will it take to reverse this harmful and unnecessary vaccination program. Gardasil 9 is now part of the school vaccination program offered freely to all teenagers. We have to continue to spread the word about these HPV vaccines.
One thing is certain we are sure to see more court action as the injuries escalate.
UK boys and their parents are able to breathe a sigh of relief after the decision has finally been made on whether to vaccinate boys against the human papilloma virus (HPV). The Joint Committee on Vaccination and Immunisation (JCVI) has been considering whether to include boys along with girls in the current vaccination program since 2014. There have been ongoing campaigns aimed at a ‘gender-neutral‘ approach to the vaccination, that would make sure that 400,000 school-age boys are able to access HPV vaccines. The committee made its recent decision based on their findings that it wouldn’t be cost-effective to vaccinate boys along with girls. Unlike the situation in the UK, in Australia there was no such deliberation and in 2013 we became the first country to extend our HPV vaccination program to boys. We cannot afford the luxury of relaxed breathing – in fact none of us can while the Gardasil vaccination program continues.
As I have written in Gardasil: Fast-Tracked and Flawed:
The roll-out of Gardasil was preceded by years of promotion by the manufacturer Merck (USA) and CSL Ltd, the New Zealand and Australian distributor culminating in a relentless propaganda campaign waged by both Australian and international mass media. Behind the Australian Gardasil campaign was the PR giant Edelman that worked with the Australian and New Zealand distributor CSL Biotherapies in promoting the vaccine to health professionals and the public. There were 974 pieces of media devoted to the campaign with over 40 hours of coverage available to the Australian audience of almost 24 million. The campaign engaged 21 women between the ages of 14–26 who were to be given the vaccination nationally. Gardasil was launched to the public on 28 August 2006 and Ian Frazer himself vaccinated the first woman at the Sydney launch.
In The Re-selling of Gardasil, blogger Lynn McTaggart has written: And now this vaccine with one of the worse track records in vaccine history, is being resold to boys. And when it comes to vaccines, where the US leads, the UK meekly follows. But this time UK has said no – for the time being at least. But it may be pressured to change this decision for as we know in the lead up to the introduction of HPV vaccines for young girls the media message was intense and scarcely a day passed without a cervical cancer story. This time the pressure is on to vaccinate boys against HPV for cancers linked to oral sex. But are young girls and boys and their parents making an informed consent to the vaccination? Are they informed that there are over 73000 reported serious adverse health effects occurring after HPV vaccination. These include death, seizures, paralysis, autoimmune diseases, chronic fatigue, pulmonary embolism, cardiac arrhythmias, infertility, cervical cancer and in boys there are now reported cases of erectile dysfunction following HPV vaccination. This would no doubt be of concern to young pubescent boys.
This current wave of re-selling Gardasil is being aided by the mantra of gender equality. Boys need HPV vaccine, too, according to the Centers for Disease Control and Prevention. According to the CDC every year in the United States around 11,000 men get cancers caused by human papillomavirus (HPV) infections. Scary reports of young men and throat cancer abound, but just as in the case of cervical cancer the human papilloma virus may well be present in many cancers but it may just be a passenger virus. According to the authors of ‘What if HPV does NOT cause cervical cancer?’ Norma Erickson and Peter Duesberg, the pieces of inactive HPV DNA that can be found in cervical cancers are from infections or warts that occurred 20-50 years before the cancer. There other factors at play. For example smoking and other environmental toxins may be the real causative factors. But once again the search for truth is forsaken when there is profit to be made.
As Lynn McTaggart concludes: We failed to lock up our daughters away from this terrible vaccine. But there’s still time to lock up our sons. Not in the United States, Australia and New Zealand where the boys are already being vaccinated.